ArticleJournal of diabetes science and technology2020
The YSI 2300 Analyzer Replacement Meeting Report.
Article in Journal of diabetes science and technology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Review
- Continuous glucose monitoring system in diabetes in pregnancy: a narrative review.Diabetology & metabolic syndrome · 2025Review
- Development of an isotope dilution gas chromatography - mass spectrometry candidate reference measurement procedure for glucose in human serum.Journal of mass spectrometry and advances in the clinical lab · 2025Article
- Improving the Bias of Comparator Methods in Analytical Performance Assessments Through Recalibration.Journal of diabetes science and technology · 2024Article
- A Newly FDA-Cleared Benchtop Glucose Analyzer Heralds the Dawn of the Post-YSI 2300 Era.Journal of diabetes science and technology · 2023Article
- Evaluation of Trueness and Precision of a Bench-Top Laboratory Glucose Analyzer Using Reference Materials.Journal of diabetes science and technology · 2022Article
- Do We Need the Replacement of YSI 2300? A View from the Clinical Laboratory.Journal of diabetes science and technology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This is a summary report of the most important aspects discussed during the YSI 2300 Analyzer Replacement Meeting. The aim is to provide the interested reader with an overview of the complex topic and propose solutions for the current issue. This solution should not only be adequate for the United States or Europe markets but also for all other countries. The meeting addendum presents three outcomes of the meeting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.